Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma
Chari, Ajai, Lonial, Sagar, Mark, Tomer M., Krishnan, Amrita Y., Stockerl‐Goldstein, Keith E., Usmani, Saad Z., Londhe, Anil, Etheredge, Delores, Fleming, Sarah, Liu, Baolian, Ukropec, Jon, Lin, Thomas S., Jagannath, Sundar, Nooka, Ajay K.
Published in Cancer (15.11.2018)
Published in Cancer (15.11.2018)
Get full text
Journal Article
Results of an Early Access Treatment Protocol (EAP) of Daratumumab in United States Patients with Relapsed or Refractory Multiple Myeloma
Chari, Ajai, Mark, Tomer M, Krishnan, Amrita, Stockerl-Goldstein, Keith, Usmani, Saad Z, Londhe, Anil, Etheredge, Delores, Parros, Hollee, Fleming, Sarah, Liu, Baolian, Freeman, Scott, Ukropec, Jon, Lin, Thomas, Lonial, Sagar
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Use of Montelukast to Reduce Infusion Reactions in an Early Access Treatment Protocol of Daratumumab in United States Patients with Relapsed or Refractory Multiple Myeloma
Chari, Ajai, Mark, Tomer M, Krishnan, Amrita, Stockerl-Goldstein, Keith, Usmani, Saad Z, Londhe, Anil, Etheredge, Delores, Parros, Hollee, Fleming, Sarah, Liu, Baolian, Freeman, Scott, Ukropec, Jon, Lin, Thomas, Nooka, Ajay K
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article